Hydrastis Canadensis 1 X Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02234544) held by Dolisos Canada Inc., containing Hydrastis Canadensis. Health Canada lists its status as Cancelled Post Market (status date 24 Apr 2006). Nexara Health has matched 11 registrations of Hydrastis Canadensis across 2 other regulated markets.
Health Canada registration
| DIN | 02234544 |
|---|---|
| Brand name | Hydrastis Canadensis |
| Active ingredient | Hydrastis Canadensis |
| Strength | 1 X |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 24 Apr 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Hydrastis Canadensis registered in other markets
11 registrations of the same molecule in 2 national registries outside Canada (first 9 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United Arab Emirates | Hydrastis Canadensis - Boiron | BOIRON, France, Messimy | MT - 200 CH | Pillules | Active | EDE |
| United States | Hydrastis Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Hydrastis Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Hydrastis Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Hydrastis Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Hydrastis Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Hydrastis Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Hydrastis Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Hydrastis Canadensis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Hydrastis Canadensis worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Hydrastis Canadensis (DIN 02234544) marketed in Canada?
No. Health Canada lists DIN 02234544 as Cancelled Post Market as of 24 Apr 2006.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Hydrastis Canadensis registered outside Canada?
Yes — Nexara Health has matched 11 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02234544, status date 2006-04-24; national medicine registries: EDE, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02234544, status date 2006-04-24; national medicine registries: EDE, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02234544, status date 2006-04-24; national medicine registries: EDE, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.